Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.085 | 0.8 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |